Comparison of immunogenicity test methods used in clinical studies of infliximab and its biosimilar (CT-P13)

Home > References > 2015 > Comparison of immunogenicity test methods used in clinical studies of infliximab and its biosimilar (CT-P13)

Contact an Account Manager

Ji Soo Kim, Sung Hwan Kim, ByoungOh Kwon & SeungSuh Hong

Year		2015
Volume		11
Page Numbers		33-41
Application		Immunogenicity , Clinical Immunology

By Analytes

By Applications

Customer Service/Orders
1-240-314-2795

5:00 a.m. to 8:00 p.m.
US Eastern Time

Email

Scientific/Technical Support
1-240-314-2798

8:30 a.m. to 5:30 p.m.
US Eastern Time

Email

Instrument Support
1-301-947-2057

8:30 a.m. - 5:30 p.m.
US Eastern Time

Email

Company Headquarters
1-240-314-2600
1601 Research Blvd.
Rockville, Maryland 20850-3173
USA

Please Sign In